Oramed Pharmaceuticals Inc (ORMP)

NASDAQ
Currency in USD
2.157
-0.023(-1.07%)
Real-time Data·
ORMP Scorecard
Full Analysis
Management has been aggressively buying back shares
ORMP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.1402.220
52 wk Range
1.8203.090
Key Statistics
Edit
Prev. Close
2.18
Open
2.17
Day's Range
2.14-2.22
52 wk Range
1.82-3.09
Volume
35.32K
Average Vol. (3m)
72.81K
1-Year Change
-14.84%
Book Value / Share
3.45
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ORMP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Oramed Pharmaceuticals Inc News & Analysis

Show more

Oramed Pharmaceuticals Inc Company Profile

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.

Compare ORMP to Peers and Sector

Metrics to compare
ORMP
Peers
Sector
Relationship
P/E Ratio
−3.1x−3.5x−0.5x
PEG Ratio
0.01−0.010.00
Price / Book
0.6x1.5x2.6x
Price / LTM Sales
44.1x2.4x3.1x
Upside (Analyst Target)
49.1%164.0%47.6%
Fair Value Upside
Unlock1.6%6.7%Unlock

Earnings

Latest Release
May 28, 2025
EPS / Forecast
-0.01 / -0.05
Revenue / Forecast
-- / 500.00K
EPS Revisions
Last 90 days

ORMP Income Statement

People Also Watch

21.120
SBS
-2.85%
20.43
TIMB
-1.11%
72.01
ACLS
-1.41%
22.96
TDC
-1.08%
14.67
PSO
-1.51%

FAQ

What Is the Oramed (ORMP) Stock Price Today?

The Oramed stock price today is 2.16

What Stock Exchange Does Oramed Trade On?

Oramed is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Oramed?

The stock symbol for Oramed is "ORMP."

What Is the Oramed Market Cap?

As of today, Oramed market cap is 88.11M.

What Is Oramed's Earnings Per Share (TTM)?

The Oramed EPS (TTM) is -0.69.

When Is the Next Oramed Earnings Date?

Oramed will release its next earnings report on Aug 13, 2025.

From a Technical Analysis Perspective, Is ORMP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Oramed Stock Split?

Oramed has split 2 times.

How Many Employees Does Oramed Have?

Oramed has 4 employees.

What is the current trading status of Oramed (ORMP)?

As of Jul 07, 2025, Oramed (ORMP) is trading at a price of 2.16, with a previous close of 2.18. The stock has fluctuated within a day range of 2.14 to 2.22, while its 52-week range spans from 1.82 to 3.09.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.